Skip to main content

Akumin Inc(AKU-T)
TSX

Today's Change
Real-Time Last Update
Day Low0.51
Day High0.53
Open:0.52
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Newswire.ca
Akumin Inc. Provides Update on its Restructuring Transaction
Newswire.ca
AKUMIN ANNOUNCES LEADERSHIP TRANSITION
Newswire.ca
AKUMIN ANNOUNCES THIRD QUARTER 2023 RESULTS
Newswire.ca
Akumin Inc. Provides Update on Trading on the Toronto Stock Exchange and Stockholder Information
Newswire.ca
Akumin Inc. Reaches Agreement with Stonepeak to Become a Private Company
Newswire.ca
Akumin Announces Change of Auditor
Newswire.ca
Akumin Announces Second Quarter 2023 Results, Revised FY23 Financial Outlook and Establishment of Special Committee
Newswire.ca
Akumin to Host Second Quarter 2023 Financial Results Call on August 10, 2023
The Globe and Mail
Akumin: Bottom 25 Performing Stocks Year-to-Date on TSX (AKU)
The Globe and Mail
Akumin: Bottom 25 Performing Stocks Year-to-Date on TSX (AKU)
The Globe and Mail
Akumin: Stocks trading at Less Than Cash Value on TSX (AKU)
The Globe and Mail
Akumin: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (AKU)
Newswire.ca
Akumin appoints President and Chief Operating Officer
The Globe and Mail
Akumin: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (AKU)
Newswire.ca
Akumin Announces First Quarter 2023 Results
PR Newswire
Akumin to Host First Quarter 2023 Financial Results Call on May 11, 2023
The Globe and Mail
Monday’s analyst upgrades and downgrades
PR Newswire
Akumin Announces Full-Year 2022 Results and Provides 2023 Guidance
PR Newswire
Akumin to Host Year-end 2022 Financial Results Call on March 17, 2023
The Globe and Mail
Akumin: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (AKU)
The Globe and Mail
Akumin: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (AKU)
The Globe and Mail
Akumin: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (AKU)
Newswire.ca
Akumin Announces Appointment of New Directors
The Globe and Mail
Akumin: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (AKU)
PR Newswire
Akumin Announces Third Quarter 2022 Results
Newswire.ca
Akumin to Host Third Quarter 2022 Financial Results Call on November 10, 2022
The Globe and Mail
Akumin: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (AKU)
The Globe and Mail
Akumin: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (AKU)

Profile

Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.